Wall Street is positive on Bio-Rad Laboratories, Inc. Class A Common Stock (BIO). On average, analysts give the stock a Strong Buy rating. The average price target is $876.666, which means analysts expect the stock to add by 17.39% over the next twelve months.
That average ranking earns the stock an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating BIO a Strong Buy today. Find out what this means to you and get the rest of the rankings on BIO!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Bio-Rad Laboratories, Inc. Class A Common Stock Stock Today?
Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is trading at $746.77 as of 2:26 PM on Thursday, Nov 11, a gain of $10.72, or 1.46% from the previous closing price of $736.05. The stock has traded between $736.09 and $748.60 so far today. Volume today is light. So far 35,127 shares have traded compared to average volume of 109,446 shares.
Click Here to get the full Stock Report for Bio-Rad Laboratories, Inc. Class A Common Stock stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
